Related Experiment Video
Updated: Sep 22, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
A novel predictor in patients with coronary chronic total occlusion: systemic immune-inflammation index: a
Muhammed Demir1, Mehmet Özbek1
1Dicle University, School of Medicine, Department of Cardiology - Diyarbakır, Turkey.
Insights
The systemic immune-inflammation index predicts mortality in chronic coronary total occlusion patients but not other adverse cardiovascular events. Higher index scores correlate with lower survival and myocardial infarction-free survival rates.
Area of Science:
- Cardiology
- Inflammation Research
- Prognostic Biomarkers
Background:
- Severe inflammation is linked to cardiovascular events, particularly in coronary artery disease patients.
- The prognostic significance of the systemic immune-inflammation index (SII) in chronic coronary total occlusion (CTO) requires further investigation.
Purpose of the Study:
- To evaluate the prognostic value of the systemic immune-inflammation index (SII) in predicting mortality and clinical outcomes.
- To determine the association between SII and major adverse cardiovascular events in patients with CTO.
Main Methods:
- A cohort of 366 consecutive patients with CTO was analyzed.
- Clinical endpoints included all-cause mortality, target vessel revascularization, myocardial infarction, and cerebrovascular events over a median follow-up of 49 months.
- Statistical analyses comprised multivariate logistic and Cox regression, and Kaplan-Meier survival analysis.
Main Results:
- The systemic immune-inflammation index (SII) was significantly associated with all-cause mortality (multivariate Cox regression).
- Higher SII scores were linked to reduced survival rates and myocardial infarction-free survival.
- SII did not show a significant association with target vessel revascularization, myocardial infarction, or cerebrovascular events.
Conclusions:
- The systemic immune-inflammation index (SII) is a valuable tool for predicting mortality in patients with chronic coronary total occlusion.
- SII demonstrated limited utility in predicting other adverse cardiovascular outcomes such as myocardial infarction or stroke.
- Larger multicenter studies are recommended to further elucidate the role of SII in clinical outcomes for CTO patients.
Objective:
Severe inflammation is reportedly associated with subsequent cardiovascular events, including in patients with coronary artery disease. This study aimed to examine the prognostic value of systemic immune-inflammation index and determine mortality and clinical outcomes in patients with chronic coronary total occlusion.
Methods:
Our study evaluated 366 consecutive coronary total occlusion patients. The clinical end points were all-cause mortality and major adverse cardiovascular events, which include target vessel revascularization, myocardial infarction, and cerebrovascular events during 105 months follow-up.
Results:
The study findings showed 59 (16.1%) all-cause death, 22 (6%) target vessel revascularization cases, 32 (8.7%) myocardial infarction cases, and 13 (3.6%) cerebrovascular events cases, with a median follow-up of 49 months (26-74). Multivariate logistic regression analysis showed that systemic immune-inflammation index was not associated with target vessel revascularization, myocardial infarction, and cerebrovascular events. Multivariate Cox regression analysis found systemic immune-inflammation index to be associated with all-cause death. Kaplan-Meier analysis showed a lower survival rate and myocardial infarction-free survival time in patients with higher systemic immune-inflammation index scores.
Conclusion:
Although systemic immune-inflammation index is a preferable tool for the detection of mortality, it failed to give adverse outcomes. Larger multicenter studies are thus warranted to investigate the effect of systemic immune-inflammation index on clinical outcomes.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology